.png)
Research Update: The Moebius-Plus RCEM Case Report Is Now Published
A few months ago, we began sharing a story about an unusual finding involving a child with Moebius syndrome.
At the time, the research had not yet been formally published.
Now it has.
On September 17, 2026, the case report, “Moebius-Plus Phenotype With Positive RCEM Episignature May Indicate Broader Embryologic Malformation Spectrum Detectable by Methylation Profiling,” was published in the American Journal of Medical Genetics Part A. PubMed
For those who have followed Parts One and Two of our Research Explained series, this gives us an opportunity to close the loop on the story that started this discussion.
How This Started
Many Faces of Moebius Syndrome first learned about this research when the mother of the child described in the case report contacted us.
Her son has Moebius syndrome along with a number of additional medical and developmental differences. After extensive genetic testing did not provide an explanation, his medical team used another type of testing that looks at patterns of DNA methylation.
That testing found something unusual.
His methylation pattern showed similarities to a pattern associated with recurrent constellations of embryonic malformations, or RCEM.
The researchers describe the result as a “moderately positive” RCEM methylation signature, matching two of three previously validated RCEM classifier models. According to the authors, this is the first reported case of a person with Moebius syndrome and a positive RCEM episignature. PubMed
That is what originally caught our attention.
What Publication Changes
Publication doesn't suddenly prove a connection between RCEM and Moebius syndrome.
It doesn't establish a new cause of Moebius syndrome.
And it doesn't mean that people with Moebius syndrome should assume they have this methylation pattern.
What has changed is that this case is now part of the published scientific literature.
Other researchers can find it. They can examine the findings, compare them with other cases and ask whether similar methylation patterns appear in other people with Moebius syndrome—particularly those who have additional congenital differences sometimes described as Moebius-plus.
The authors themselves say the finding suggests a possible common embryologic pathway and propose that episignature testing could be useful in some people with Moebius syndrome and related craniofacial-limb malformation patterns when conventional genomic testing has not provided an answer. PubMed
Those are possibilities for further investigation, not settled conclusions.
One Case Still Means One Case
This may be the most important thing to remember.
This research describes one child.
A case report can identify something researchers haven't seen before. It can raise a question worth pursuing. Sometimes it can point researchers in a new direction.
But it cannot tell us how common a finding is among people with Moebius syndrome or establish that the same biological process is responsible for other cases.
Answering those questions would require studying considerably more people.
So while publication is an important milestone, our message hasn't changed from Parts One and Two:
This is a clue, not an answer.
Why We Followed This Story
This entire Research Explained series started because one mother wanted information about her son's unusual findings to reach people who might be able to learn from it.
She didn't come to us claiming that researchers had discovered the cause of Moebius syndrome. In fact, she was trying to better understand what the complicated scientific findings meant herself.
That led us to start reading.
And the more we read, the more we realized there was a larger story worth explaining—not because we know where this research will lead, but because people with Moebius syndrome and their families deserve the opportunity to understand research involving their condition.
That is what MFOMS Research Explained is intended to do.
We aren't conducting the research, and we aren't interpreting these findings as medical advice. Our goal is much simpler: when meaningful Moebius syndrome research becomes available, we want to help make it understandable to the people it is ultimately about.
Where Does This Go From Here?
For now, we wait.
Researchers will have to determine whether this finding appears in other people with Moebius syndrome. Larger studies would be needed to determine whether there is a reproducible relationship between Moebius syndrome, RCEM-associated methylation patterns and early embryonic development.
The published paper itself notes that most people with Moebius syndrome remain genetically unexplained, despite advances in genomic testing. PubMed
Perhaps this finding will eventually become an important piece of that puzzle.
Perhaps further research will show that it applies only to a very small and specific group.
That's how research works. One finding leads to another question.
When we first learned about this case, it came to us through a mother who wanted to make sure information about her son's unusual findings reached people who might be able to learn from it.
At the time, the research had not yet been published.
Now it has.
That doesn't mean the mystery has been solved.
It means one more piece of information has entered the scientific record, where researchers can examine it, question it, compare it with other cases and decide where the research should go next.
For now, that may be the most important development of all.
Published Research
Peck H, Krueger LA, Sperry ED, et al. Moebius-Plus Phenotype With Positive RCEM Episignature May Indicate Broader Embryologic Malformation Spectrum Detectable by Methylation Profiling. American Journal of Medical Genetics Part A. Published September 17, 2026. DOI: 10.1002/ajmg.a.70300. PubMed
Comments